Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors.

Walter, Yohan; Hubbard, Anne; Benoit, Allie; Jank, Erika; Salas, Olivia; Jordan, Destiny; Ekpenyong, Andrew

Walter, Yohan; Hubbard, Anne; Benoit, Allie; Jank, Erika; Salas, Olivia; Jordan, Destiny; Ekpenyong, Andrew.

Afiliação

Walter Y; Department of Physics, Creighton University, Omaha, NE 68178, USA.
Hubbard A; Department of Physics, Creighton University, Omaha, NE 68178, USA.
Benoit A; Department of Physics, Creighton University, Omaha, NE 68178, USA.
Jank E; Department of Physics, Creighton University, Omaha, NE 68178, USA.
Salas O; Department of Physics, Creighton University, Omaha, NE 68178, USA.
Jordan D; Department of Biology, Creighton University, Omaha, NE 68178, USA.
Ekpenyong A; Department of Physics, Creighton University, Omaha, NE 68178, USA.

Biomedicines ; 10(8)2022 Jul 26.

Article em En | MEDLINE | ID: mdl-35892697

Palavras-chave

brain cancers; durvalumab; glioblastoma; immune checkpoint inhibitors; immunoradiotherapy; immunotherapy; radioimmunotherapy; radiotherapy; temozolomide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article